piperine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases alanine aminotransferase
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“After the trial interval, concentrations of ALT and AST in the case group were statistically decreased compared with the control group with a P value < 0.001 and a P value of 0.002, respectively.”
Quoted verbatim from The impact of piperine on the metabolic conditions of patients with NAFLD and early cirrhosis: a randomized double-blind controlled trial.. - Study
- RCT
- Duration
- 3 months
- Dose
- 5 mg piperine capsule daily
- Population
- Adults with ultrasound grade 2-3 NAFLD and raised ALT, Iran
The impact of piperine on the metabolic conditions of patients with NAFLD and early cirrhosis: a randomized double-blind controlled trial.2024PMID:38200253Permalink
Keep reading
- Everything the graph holds on piperine
- Every compound studied against Alanine aminotransferase
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PGW4YTFNN69NNAFE250RSZ